Remove 2007 Remove Food and Drug Administration Remove Healthcare
article thumbnail

Innovating allergy drug delivery with a needle-free alternative

European Pharmaceutical Review

This decision was granted a couple of weeks following approval by the US and Drug Administration (FDA). Approximately 40 million people in the US experience Type I allergic reactions due to food, venom or insect stings, 4 and the numbers are similar in Europe. 2007; 2(1):5-11. Hand (N Y). Lowenthal R.

article thumbnail

Interview: Dr Alan S Louie – US Food and Drug Administration Delays

Pharmaceutical Technology

Nicola Boyes: The FDA has come under criticism recently for extreme delays in approving new drugs for the market, is the criticism valid and if so how are the delays impacting on the US pharmaceutical industry at present? This higher threshold, although not explicit, would also be expected to slow drug approvals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Effective Pharma Ad Types & Stats

Pharma Marketing Network

Pharmaceutical advertising is a crucial aspect of promoting and marketing drugs to the public. Professional Advertising: Professional advertising, also known as Direct-to-Professional (DTP) advertising, is another type of pharmaceutical advertising that is aimed at healthcare professionals such as doctors, nurses, and pharmacists.

Pharma 52
article thumbnail

Developing a holistic approach to cardio, metabolic and renal disease

European Pharmaceutical Review

2 The estimated annual healthcare costs associated with circulatory disease in the UK is £9 billion. This theory has been supported by the clinical results of drugs such as empagliflozin, the SGLT2 inhibitor, across several of these conditions. Within the UK alone, an estimated 7.6 2021 [cited 8 June 2022]. Available from: [link].

article thumbnail

Innovations & Challenges in Brain Health

PM360

They are difficult to diagnose early in a disease, the regulatory endpoints are often unprecedented and challenging, and many drugs struggle to get into the brain. The downside is that it also keeps most potential drug treatments from reaching the brain. healthcare system over $800 billion annually.

article thumbnail

THEPM360TRAILBLAZER AWARD WINNER – Lifetime Achievement Award – Adam Schechter, CEO and Chairman, Labcorp

PM360

Prior to becoming President of Global Human Health, he served as President of Merck’s global pharmaceutical business from 2007 to 2010. Adam is an ethical leader who leads his business to serve the needs of patients and advance healthcare globally. Food and Drug Administration (FDA) approval.

Ethics 59